AUSTRALIA- The University of Sydney has revealed its largest-ever capital commitment to creating an AU$478 million (US$330m) world-class biomedical hub in New South Wales that would accelerate patient care and research.
The Royal Prince Alfred Hospital and the University’s Camperdown campuses will both be part of the 36,000 m2 health, education, and research districts that the Sydney Biomedical Accelerator (SBA) will establish.
The University of Sydney will receive a donation of AU$73 million as part of the funding for the Sydney Biomedical Accelerator.
One of three structures that make up the Sydney Biomedical Accelerator complex, The Isaac Wakil Biomedical Building, will be established thanks to an AU$20 million gift from the Susan and Isaac Wakil Foundation.
The Accelerator will address some of the most difficult health issues, such as cancer and neurological illnesses, and will establish Sydney as a leader in biomedical research worldwide.
Researchers at the Accelerator will focus on the most recent advances in nanotechnology, gene therapy, and stem cell research.
The impact of the same will be on the state’s health outcomes in the areas of regenerative medicine, medication discovery, and medical device development.
This is a historic investment for any University. The range of world-class buildings and facilities that will make up the Sydney Biomedical Accelerator will bring together the brightest scientific and clinical minds with entrepreneurs, industry and government
The investment, according to Vice-Chancellor and President Professor Mark Scott AO, is an essential aspect of the University’s new 10-year strategy.
“This is a historic investment for any University. The range of world-class buildings and facilities that will make up the Sydney Biomedical Accelerator will bring together the brightest scientific and clinical minds with entrepreneurs, industry and government,” Professor Scott said.
She highlighted that it gives their renowned researchers and partners the infrastructure to take a major step forward in the global quest to find solutions to our biggest health challenges.
She believes that together, they have the potential to dramatically improve the future of health and medical care in this Australia.
The Accelerator has been compared to the top biomedical facilities in the world, including, the University of Toronto’s MaRS Discovery District, and the Karolinska Institutet.
At the SBA, more than 1200 top-tier biomedical researchers and clinician scientists will work alongside over 800 Ph.D. students and researchers from university laboratories.
The project will put Sydney at the forefront of international biomedical research, allowing it to draw in talent from around the world and hasten the commercialization of discoveries.
Initial construction on the Sydney Biomedical Accelerator will start this year, and occupancy is anticipated to start in 2026.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE